DE69807466D1 - Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten - Google Patents

Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten

Info

Publication number
DE69807466D1
DE69807466D1 DE69807466T DE69807466T DE69807466D1 DE 69807466 D1 DE69807466 D1 DE 69807466D1 DE 69807466 T DE69807466 T DE 69807466T DE 69807466 T DE69807466 T DE 69807466T DE 69807466 D1 DE69807466 D1 DE 69807466D1
Authority
DE
Germany
Prior art keywords
triptolid
treatment
autoimmune diseases
derivatives useful
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69807466T
Other languages
English (en)
Other versions
DE69807466T2 (de
Inventor
J Jung
Mahinda Wickramaratne
Michael Hepperle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69807466D1 publication Critical patent/DE69807466D1/de
Application granted granted Critical
Publication of DE69807466T2 publication Critical patent/DE69807466T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
DE69807466T 1997-05-23 1998-04-27 Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten Expired - Lifetime DE69807466T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86248897A 1997-05-23 1997-05-23
PCT/US1998/008470 WO1998052951A1 (en) 1997-05-23 1998-04-27 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Publications (2)

Publication Number Publication Date
DE69807466D1 true DE69807466D1 (de) 2002-10-02
DE69807466T2 DE69807466T2 (de) 2003-04-24

Family

ID=25338616

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69807466T Expired - Lifetime DE69807466T2 (de) 1997-05-23 1998-04-27 Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten

Country Status (21)

Country Link
EP (1) EP0983275B1 (de)
JP (1) JP2001525851A (de)
KR (1) KR20010012822A (de)
CN (1) CN1257507A (de)
AR (1) AR012723A1 (de)
AT (1) ATE222910T1 (de)
AU (1) AU741917B2 (de)
BR (1) BR9809678A (de)
CA (1) CA2287977A1 (de)
DE (1) DE69807466T2 (de)
DK (1) DK0983275T3 (de)
ES (1) ES2178207T3 (de)
HK (1) HK1026096A1 (de)
HU (1) HUP0003398A3 (de)
IL (1) IL133088A0 (de)
NO (1) NO995723L (de)
NZ (1) NZ500762A (de)
PT (1) PT983275E (de)
TW (1) TW434235B (de)
WO (1) WO1998052951A1 (de)
ZA (1) ZA984174B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329148B1 (en) 1999-02-16 2001-12-11 The Board Of Trustees Of The Leland Stanford University Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
CA2448795A1 (en) * 2001-03-15 2002-09-26 Pharmagenesis, Inc. Amino acid derivatives of triptolide compounds as immune modulators and anticancer agent
WO2003101951A2 (en) * 2002-05-31 2003-12-11 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
CN100398544C (zh) * 2002-09-18 2008-07-02 成都达远药物有限公司 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
JP2006513209A (ja) * 2002-12-17 2006-04-20 ファーマジェネシス， インコーポレイテッド 免疫調節因子および抗癌剤としてのトリプトライド誘導体
CN1223595C (zh) * 2002-12-27 2005-10-19 中国科学院上海药物研究所 雷公藤内酯醇衍生物及其应用
US6943259B2 (en) * 2003-02-25 2005-09-13 Pharmagenesis, Inc. Halogenated triptolide derivatives as immunomodulators and anticancer agents
US7820834B2 (en) 2003-12-24 2010-10-26 Pharmagenesis, Inc. Triptolide 5,6-derivatives as immunomodulators and anticancer agents
CN1917893A (zh) 2004-02-09 2007-02-21 美国泛华医药公司 从雷公藤多苷中分离雷公藤内酯醇化合物的方法
US7863464B2 (en) 2004-03-02 2011-01-04 Pharmagenesis, Inc. Triptolide lactone ring derivatives as immunomodulators and anticancer agents
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
WO2006044496A2 (en) 2004-10-13 2006-04-27 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
JP5653939B2 (ja) * 2009-02-05 2015-01-14 ファーマジェネシス， インコーポレイテッド 抗癌剤および免疫調節因子としてのトリプトリドｃ環誘導体
WO2017070878A1 (zh) 2015-10-29 2017-05-04 徐荣臻 C14-位羟基酯化的雷公藤甲素氨基酸衍生物、及其制备方法和应用
CN114716503B (zh) * 2022-03-23 2024-03-12 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 一种雷公藤氯内酯醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
AR012723A1 (es) 2000-11-08
BR9809678A (pt) 2000-07-11
AU741917B2 (en) 2001-12-13
HK1026096A1 (en) 2000-12-01
ZA984174B (en) 1998-11-23
JP2001525851A (ja) 2001-12-11
TW434235B (en) 2001-05-16
EP0983275A1 (de) 2000-03-08
CN1257507A (zh) 2000-06-21
NO995723L (no) 2000-01-21
WO1998052951A1 (en) 1998-11-26
PT983275E (pt) 2003-01-31
AU7260798A (en) 1998-12-11
CA2287977A1 (en) 1998-11-26
DK0983275T3 (da) 2002-12-23
KR20010012822A (ko) 2001-02-26
ES2178207T3 (es) 2002-12-16
HUP0003398A3 (en) 2001-09-28
HUP0003398A2 (en) 2001-03-28
IL133088A0 (en) 2001-03-19
EP0983275B1 (de) 2002-08-28
DE69807466T2 (de) 2003-04-24
ATE222910T1 (de) 2002-09-15
NZ500762A (en) 2001-08-31
NO995723D0 (no) 1999-11-22

Similar Documents

Publication Publication Date Title
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE241977T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE69835011D1 (de) Unterschiedliche behandlung von prothesenteilen
ATE308527T1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69829921D1 (de) Vorrichtung zur Behandlung von Körpergewebe
ATE224189T1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US